avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf1 | mm10_v2_chr8_+_84901928_84901992 | 0.91 | 1.9e-14 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_109849440 Show fit | 24.44 |
ENSMUST00000112022.2
|
cathelicidin antimicrobial peptide |
|
chr7_-_142578139 Show fit | 24.05 |
ENSMUST00000136359.1
|
H19 fetal liver mRNA |
|
chr14_+_80000292 Show fit | 19.66 |
ENSMUST00000088735.3
|
olfactomedin 4 |
|
chr7_-_142656018 Show fit | 17.80 |
ENSMUST00000178921.1
|
insulin-like growth factor 2 |
|
chr11_+_11684967 Show fit | 17.66 |
ENSMUST00000126058.1
ENSMUST00000141436.1 |
IKAROS family zinc finger 1 |
|
chr8_+_22974844 Show fit | 15.70 |
ENSMUST00000110688.2
ENSMUST00000121802.2 |
ankyrin 1, erythroid |
|
chr9_+_111019284 Show fit | 15.08 |
ENSMUST00000035077.3
|
lactotransferrin |
|
chr17_-_26201328 Show fit | 14.56 |
ENSMUST00000025019.2
|
Rho GDP dissociation inhibitor (GDI) gamma |
|
chr12_-_4841583 Show fit | 14.29 |
ENSMUST00000020964.5
|
FK506 binding protein 1b |
|
chr6_+_86078070 Show fit | 13.22 |
ENSMUST00000032069.5
|
adducin 2 (beta) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 48.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.7 | 33.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
2.5 | 32.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
3.0 | 29.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 27.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
2.9 | 26.4 | GO:0002432 | granuloma formation(GO:0002432) |
1.5 | 24.9 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
2.9 | 23.2 | GO:0015671 | oxygen transport(GO:0015671) |
2.8 | 22.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 20.5 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 42.2 | GO:0042581 | specific granule(GO:0042581) |
5.2 | 41.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.5 | 36.1 | GO:0005844 | polysome(GO:0005844) |
0.2 | 26.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 25.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
2.5 | 25.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.2 | 24.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
5.9 | 23.6 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
1.7 | 23.1 | GO:0090543 | Flemming body(GO:0090543) |
1.4 | 21.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 49.0 | GO:0051015 | actin filament binding(GO:0051015) |
1.1 | 40.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.7 | 32.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 30.8 | GO:0030507 | spectrin binding(GO:0030507) |
3.1 | 24.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
6.1 | 24.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.6 | 21.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.4 | 20.1 | GO:0070888 | E-box binding(GO:0070888) |
1.6 | 17.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.7 | 17.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 35.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 28.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 24.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 23.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
2.6 | 20.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 18.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.0 | 18.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 18.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 17.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 15.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 37.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 25.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 25.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 22.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 21.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 21.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.8 | 20.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 18.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 18.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 13.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |